A detailed history of Founders Capital Management transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Founders Capital Management holds 14,000 shares of SGMO stock, worth $14,560. This represents 0.01% of its overall portfolio holdings.

Number of Shares
14,000
Previous 16,000 12.5%
Holding current value
$14,560
Previous $13,000 7.69%
% of portfolio
0.01%
Previous 0.01%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 13, 2025

SELL
$0.78 - $2.87 $1,560 - $5,740
-2,000 Reduced 12.5%
14,000 $14,000
Q3 2024

Oct 07, 2024

BUY
$0.32 - $1.1 $1,920 - $6,600
6,000 Added 60.0%
16,000 $13,000
Q1 2024

Apr 10, 2024

BUY
$0.42 - $1.38 $3,360 - $11,040
8,000 Added 400.0%
10,000 $6,000
Q4 2023

Jan 08, 2024

SELL
$0.3 - $0.63 $600 - $1,260
-2,000 Reduced 50.0%
2,000 $1,000
Q1 2023

Apr 12, 2023

BUY
$1.66 - $3.67 $3,320 - $7,340
2,000 Added 100.0%
4,000 $7,000
Q4 2022

Jan 09, 2023

BUY
$2.77 - $5.07 $2,770 - $5,070
1,000 Added 100.0%
2,000 $6,000
Q3 2021

Oct 12, 2021

BUY
$9.01 - $12.01 $9,010 - $12,010
1,000 New
1,000 $9,000

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $163M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Founders Capital Management Portfolio

Follow Founders Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Founders Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Founders Capital Management with notifications on news.